Non-small cell lung cancer+1
RecruitingStudy of Durvalumab, Tremelimumab, Chemotherapy, and Radiotherapy for Patients with Newly Diagnosed Non-Small Cell Lung Cancer with Limited Spread
Study of Durvalumab, Tremelimumab, Chemotherapy, and Radiotherapy for Patients with Newly Diagnosed Non-Small Cell Lung Cancer with Limited Spread
- Disease:Non-small cell lung cancerNon-small cell lung cancer metastatic
- Substances:DurvalumabTremelimumab
Italy- Participants:18–64 years · 65+ years
- Substances:Durvalumab
- Sponsor:ETOP IBCSG Partners Foundation









